Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Recruiting

Phase 1

Gemcitabine & DocetaxelGemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Sponsor:

Wake Forest University Health Sciences

Code:

NCT04037527

Conditions

Soft Tissue Sarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine

Docetaxel

Radiation

Surgical Resection

Blood draws

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-25. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2025-03-20.